Carlyle acquires J&J’s diagnostics unit in $4bn deal


blood cells_sqPrivate equity major Carlyle has agreed to buy Johnson & Johnson’s diganostics unit in a $4bn deal.

Ortho-Clinical Diagnostics posted sales of $1.89bn last year, which accounted for 2.6 per cent of J&J’s total revenues. The company medical screening, diagnosis and monitoring equipment in 130 countries.

Carlyle agreed a deal to buy the unit for what at the time was reported to be $4.15bn in January.

Bain Capital, BC Partners and the pairing of Leonard Green & Partners and CVC Capital were previously said to be interested in buying the business.

Carlyle said equity for the deal came from Carlyle Partners VI, the $13bn US buyout fund it closed in November 2013.

Copyright © 2014 AltAssets